DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G. et al.
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): An international, open-label, randomised, controlled, phase 3, multicentre trial.
Lancet Oncol 2017;
18: 812-22
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.